| Nome |
# |
|
null, file e0d6c926-e0cd-fcf8-e053-d805fe0aa794
|
349
|
|
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration, file e0d6c927-a94b-fcf8-e053-d805fe0aa794
|
175
|
|
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity, file e0d6c92a-dc68-fcf8-e053-d805fe0aa794
|
174
|
|
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation, file e0d6c92b-201f-fcf8-e053-d805fe0aa794
|
149
|
|
Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon, file e0d6c927-a474-fcf8-e053-d805fe0aa794
|
144
|
|
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models, file e0d6c927-d8b0-fcf8-e053-d805fe0aa794
|
143
|
|
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention, file e0d6c92b-70ab-fcf8-e053-d805fe0aa794
|
129
|
|
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats, file e0d6c926-61f7-fcf8-e053-d805fe0aa794
|
122
|
|
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity, file e0d6c92a-c0ea-fcf8-e053-d805fe0aa794
|
120
|
|
Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation, file e0d6c928-fef4-fcf8-e053-d805fe0aa794
|
105
|
|
Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?, file e0d6c92b-5c11-fcf8-e053-d805fe0aa794
|
86
|
|
High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse, file e0d6c92d-8ed8-fcf8-e053-d805fe0aa794
|
77
|
|
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity, file e0d6c92b-47a6-fcf8-e053-d805fe0aa794
|
71
|
|
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients, file e0d6c92e-9faf-fcf8-e053-d805fe0aa794
|
44
|
|
AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases, file e0d6c92b-d9eb-fcf8-e053-d805fe0aa794
|
36
|
|
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic, file e0d6c931-2dd4-fcf8-e053-d805fe0aa794
|
22
|
|
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition, file e0d6c92e-cb49-fcf8-e053-d805fe0aa794
|
20
|
|
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy, file e0d6c92e-1e5e-fcf8-e053-d805fe0aa794
|
13
|
|
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats, file e0d6c927-96ab-fcf8-e053-d805fe0aa794
|
11
|
|
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?, file e0d6c92e-d9f3-fcf8-e053-d805fe0aa794
|
11
|
|
Dietary flavonoids as a potential intervention to improve redox balance in obesity and related co-morbidities: a review, file e0d6c92a-b9ab-fcf8-e053-d805fe0aa794
|
8
|
|
Ectopic Lymphoid Organs and Immune-Mediated Diseases: Molecular Basis for Pharmacological Approaches, file e0d6c92f-69a1-fcf8-e053-d805fe0aa794
|
8
|
|
Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer’s Disease, file e0d6c931-3d9d-fcf8-e053-d805fe0aa794
|
7
|
|
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia, file e0d6c92e-fc65-fcf8-e053-d805fe0aa794
|
6
|
|
Intestinal epithelial barrier and neuromuscular compartment in health and disease, file e0d6c92e-f354-fcf8-e053-d805fe0aa794
|
5
|
|
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same?, file e0d6c929-1c20-fcf8-e053-d805fe0aa794
|
4
|
|
Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases, file e0d6c92d-5d76-fcf8-e053-d805fe0aa794
|
4
|
|
Differential Impact of Weight Loss and Glycemic Control on Inflammasome Signaling, file e0d6c92e-a47d-fcf8-e053-d805fe0aa794
|
4
|
|
The administration of Enterococcus faecium SF68 counteracts compositional shifts in the gut microbiota of diet-induced obese mice, file 2a200fac-8902-427c-8e96-4c1f0a3a06b1
|
3
|
|
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications, file e0d6c926-3b4c-fcf8-e053-d805fe0aa794
|
3
|
|
Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rat, file e0d6c926-458b-fcf8-e053-d805fe0aa794
|
3
|
|
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders, file e0d6c927-9636-fcf8-e053-d805fe0aa794
|
3
|
|
null, file e0d6c929-5471-fcf8-e053-d805fe0aa794
|
3
|
|
null, file e0d6c931-3067-fcf8-e053-d805fe0aa794
|
3
|
|
From the intestinal mucosal barrier to the enteric neuromuscular compartment: an integrated overview on the morphological changes in Parkinson's disease, file e0d6c931-49c5-fcf8-e053-d805fe0aa794
|
3
|
|
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models, file e0d6c927-a058-fcf8-e053-d805fe0aa794
|
2
|
|
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors, file e0d6c929-bf42-fcf8-e053-d805fe0aa794
|
2
|
|
Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy, file e0d6c92b-ee39-fcf8-e053-d805fe0aa794
|
2
|
|
NKG2A and COVID-19: another brick in the wall, file e0d6c92e-a7ea-fcf8-e053-d805fe0aa794
|
2
|
|
Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity, file e0d6c92e-ce73-fcf8-e053-d805fe0aa794
|
2
|
|
Editorial: IBD Management—Novel Targets and Therapeutic Perspectives, file e0d6c92e-f936-fcf8-e053-d805fe0aa794
|
2
|
|
Deepening the Mechanisms of Visceral Pain Persistence: An Evaluation of the Gut-Spinal Cord Relationship, file e0d6c92f-1b04-fcf8-e053-d805fe0aa794
|
2
|
|
Inflammatory Bowel Diseases: It's Time for the Adenosine System, file e0d6c92f-2221-fcf8-e053-d805fe0aa794
|
2
|
|
The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis, file e0d6c92f-298f-fcf8-e053-d805fe0aa794
|
2
|
|
Enteric glia at the crossroads between intestinal immune system and epithelial barrier: Implications for parkinson disease, file e0d6c930-1e49-fcf8-e053-d805fe0aa794
|
2
|
|
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation, file e0d6c931-39a1-fcf8-e053-d805fe0aa794
|
2
|
|
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO, file e0d6c931-3e3a-fcf8-e053-d805fe0aa794
|
2
|
|
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology, file e0d6c931-d954-fcf8-e053-d805fe0aa794
|
2
|
|
Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence, file e0d6c926-a3df-fcf8-e053-d805fe0aa794
|
1
|
|
Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity, file e0d6c92b-0e88-fcf8-e053-d805fe0aa794
|
1
|
|
Approaches for designing and discovering purinergic drugs for gastrointestinal diseases, file e0d6c92e-bf9a-fcf8-e053-d805fe0aa794
|
1
|
|
The adenosine system at the crossroads of intestinal inflammation and neoplasia, file e0d6c92f-2b8f-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c931-2f12-fcf8-e053-d805fe0aa794
|
1
|
|
Donepezil improves vascular function in a mouse model of Alzheimer's disease, file e0d6c931-860d-fcf8-e053-d805fe0aa794
|
1
|
|
Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis, file e0d6c931-c85c-fcf8-e053-d805fe0aa794
|
1
|
| Totale |
2101 |